全球球囊瓣環成形裝置市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計球囊瓣環成形裝置市場將從 2025 年的 32.5 億美元成長到 2034 年的 51.3 億美元，2026 年至 2034 年的複合年成長率為 5.19%。

由於主動脈瓣狹窄和二尖瓣狹窄等心臟瓣膜疾病的盛行率不斷上升，全球球囊瓣環成形器械市場正經歷顯著成長。球囊瓣環成形是一種微創外科手術，可透過擴張狹窄的心臟瓣膜來改善血流。微創技術在心臟治療領域的日益普及也推動了該市場的成長。

心血管疾病發生率的上升以及易患心臟瓣膜疾病的老年人口不斷增加，推動了這個市場的發展。導管介入器械和影像技術的進步正在提高球囊瓣環成形的安全性和有效性。

隨著介入性心臟病學技術的進步，市場預計將持續成長。更精準、更耐用的球囊導管系統的研發將有助於改善治療效果。隨著醫療機構擴大選擇微創心臟治療，球囊瓣環成形裝置的市場預計將穩定擴張。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球球囊瓣環成形裝置市場：依產品類型分類

• 市場分析、洞察與預測
• 標準氣球
• 切割球囊
• 球囊導管
• 高壓氣球
• 低壓氣球

第5章：全球球囊瓣環成形裝置市場：依應用分類

• 市場分析、洞察與預測
• 主動脈瓣狹窄
• 肺動脈瓣狹窄

第6章：全球球囊瓣環成形裝置市場：依年齡層別分類

• 市場分析、洞察與預測
• 兒童
• 成人

第7章 全球球囊瓣環成形裝置市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 門診手術中心
• 專科診所
• 其他最終用戶

第8章 全球球囊瓣環成形裝置市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton
  • Dickinson And Company
  • Boston Scientific Corporation
  • Cardinal Health Inc
  • Cook Medical LLC
  • Edwards Lifesciences Corporation
  • Innomed Medical Development Ltd
  • JOTEC GmbH
  • Medtronic Plc
  • MicroPort Scientific Corporation
  • NuMED Canada Inc
  • NuMED Inc
  • Osypka Medical GmbH
  • Teleflex Incorporated

The Balloon Valvuloplasty Devices Market size is expected to reach USD 5.13 Billion in 2034 from USD 3.25 Billion (2025) growing at a CAGR of 5.19% during 2026-2034.

The Global Balloon Valvuloplasty Devices Market is witnessing significant growth due to the increasing prevalence of heart valve disorders such as aortic stenosis and mitral valve stenosis. Balloon valvuloplasty is a minimally invasive procedure used to widen narrowed heart valves and improve blood flow. The growing adoption of less invasive cardiac treatments has supported the expansion of this market.

The market is driven by the rising incidence of cardiovascular diseases and the growing aging population, which is more susceptible to heart valve conditions. Technological advancements in catheter-based devices and imaging techniques have improved the safety and effectiveness of balloon valvuloplasty procedures.

In the future, the market is expected to grow with continued advancements in interventional cardiology technologies. The development of more precise and durable balloon catheter systems will enhance procedural outcomes. As healthcare providers increasingly prefer minimally invasive cardiac treatments, the balloon valvuloplasty devices market is anticipated to expand steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Standard Balloon
• Cutting Balloon
• Scoring Balloon
• High-pressure Balloon
• Low-pressure Balloon

By Application

• Aortic Valve Stenosis
• Pulmonary Valve Stenosis

By Age Group

• Pediatric
• Adult

By End Use

• Hospitals
• Ambulatory Surgical Centres
• Specialty Clinics
• Other End Users

COMPANIES PROFILED

• Abbott Laboratories, B Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health Inc, Cook Medical LLC, Edwards Lifesciences Corporation, Innomed Medical Development Ltd, JOTEC GmbH, Medtronic plc, MicroPort Scientific Corporation, NuMED Canada Inc, NuMED Inc, Osypka Medical GmbH, Teleflex Incorporated
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BALLOON VALVULOPLASTY DEVICES MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Standard Balloon Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Cutting Balloon Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Scoring Balloon Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. High-pressure Balloon Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Low-pressure Balloon Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BALLOON VALVULOPLASTY DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Aortic Valve Stenosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Pulmonary Valve Stenosis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BALLOON VALVULOPLASTY DEVICES MARKET: BY AGE GROUP 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Age Group
• 6.2. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BALLOON VALVULOPLASTY DEVICES MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centres Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BALLOON VALVULOPLASTY DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product Type
  • 8.2.2 By Application
  • 8.2.3 By Age Group
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product Type
  • 8.3.2 By Application
  • 8.3.3 By Age Group
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product Type
  • 8.4.2 By Application
  • 8.4.3 By Age Group
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product Type
  • 8.5.2 By Application
  • 8.5.3 By Age Group
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product Type
  • 8.6.2 By Application
  • 8.6.3 By Age Group
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BALLOON VALVULOPLASTY DEVICES INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Abbott Laboratories
  • 10.2.2 B. Braun Melsungen AG
  • 10.2.3 Becton
  • 10.2.4 Dickinson And Company
  • 10.2.5 Boston Scientific Corporation
  • 10.2.6 Cardinal Health Inc
  • 10.2.7 Cook Medical LLC
  • 10.2.8 Edwards Lifesciences Corporation
  • 10.2.9 Innomed Medical Development Ltd
  • 10.2.10 JOTEC GmbH
  • 10.2.11 Medtronic Plc
  • 10.2.12 MicroPort Scientific Corporation
  • 10.2.13 NuMED Canada Inc
  • 10.2.14 NuMED Inc
  • 10.2.15 Osypka Medical GmbH
  • 10.2.16 Teleflex Incorporated